TSE: 4593 - Healios K.K.

Yield per half year: +41.67%
Sector: Healthcare

Healios K.K.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 111.03 -100% 0 0%
P/S 96.11 75.03 28.09%
P/BV 3.01 70.29 -95.72%
P/FCF -6.43 80.52 -107.99%
Ev/Ebitda -3.14 76.71 -104.09%
Ev/S 78.01 72.43 7.69%
Ev/FCF -3.31 15.5 -121.37%
E/P -0.2086 0.1179 -276.92%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-2485.12 -78.2 3077.77% -7069.42 -64.85%
ROE -99.14 -10.46 848.26%
ROA -25.23 -10.03 151.47%
ROIC 0 9.09 -100%
ROS -3159.5 -143.89 2095.73%
ROCE -87.36 2.34 -3827.42%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.51 1.08 -239.79% -2.26 -33.21%
Nеt Debt/Ebitda 0.7283 -0.3908 -286.34%
Debt/Ratio 0.299 0.1308 128.57%
Debt/Equity 4.49 6.92 -35.17%
Debt/Net Income -1.19 -1.84 -35.63%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.62 -100% 0 0%
Number of years of dividend growth 0 1.16 -100%
DSI 0 0.7238 -100%
Average dividend growth 0 -10.93 -100%
Average percentage for 5 years 0 1.88 -100%
Average percentage for payments 0 37.94 -100%
Difference from average difference in sector -2.62

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
35.96 170.19 -78.87%
Growth impulse Ebitda in 5 years -31.66 101.21 -131.28%
Growth impulse Net Income in 5 years -13.31 82.55 -116.12%
Growth impulse FCF in 5 years -43.79 104.08 -142.07%
Growth impulse EPS in 5 years -36.07 127.91 -128.2%
IP Score
2.49/10

Similar companies

Sosei Group Corporation

Taisho Pharmaceutical Holdings Co., Ltd.

Sumitomo Pharma Co., Ltd.

PHC Holdings Corporation

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription